Claire Fraser
CIK: 0001382031
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jul 8, 2026MCRB
Seres Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
6.5K shares- - Feb 25, 2026WAT
WATERS CORP /DE/
Award(A)Direct358 shares- - Sep 10, 2025BDX
BECTON DICKINSON & CO
Sale(S)Direct917 shares at avg. $187.50$172K - Aug 8, 2025BDX
BECTON DICKINSON & CO
Sale(S)Direct863 shares at avg. $192.30$166K - Jul 1, 2025MCRB
Seres Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
6.5K shares- - Apr 10, 2025MCRB
Seres Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
100K shares- - Jan 28, 2025BDX
BECTON DICKINSON & CO
Award(A)Direct930 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 8, 2026 |  MCRB Seres Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 6,500 | - | - | Direct |
| Feb 25, 2026 |  WAT WATERS CORP /DE/ | Award(A) | 358 | - | $0 | Direct |
| Sep 10, 2025 |  BDX BECTON DICKINSON & CO | Sale(S) | 917 | $187.50 | $171,938 | Direct |
| Aug 8, 2025 | BDX BECTON DICKINSON & CO | Sale(S) | 863 | $192.30 | $165,955 | Direct |
| Jul 1, 2025 | MCRB Seres Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 6,452 | - | - | Direct |
| Apr 10, 2025 | MCRB Seres Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 100,000 | - | - | Direct |
| Jan 28, 2025 | BDX BECTON DICKINSON & CO | Award(A) | 930 | - | $0 | Direct |
1-7 of 7 transactions
About Fraser Claire
Fraser Claire (SEC CIK 0001382031) files insider reports with the SEC as Director of Seres Therapeutics, Inc. (MCRB), Director of WATERS CORP /DE/ (WAT) and Director of BECTON DICKINSON & CO (BDX).
Signal8 holds 8 ownership filings by Fraser Claire (1 Form 3, 7 Form 4), filed between Jan 30, 2025 and Jul 10, 2026. Those filings report 7 transactions, from Jan 28, 2025 to Jul 8, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Fraser Claire's filings is in CAMBRIDGE, MA.
Recent filings by Fraser Claire
- Jul 8, 2026: Grant or award of MCRB derivative securities (Form 4, code A).
- Feb 25, 2026: Grant or award of WAT shares (Form 4, code A).
- Sep 10, 2025: Open-market sale of BDX shares (Form 4, code S).
- Aug 8, 2025: Open-market sale of BDX shares (Form 4, code S).
- Jul 1, 2025: Grant or award of MCRB derivative securities (Form 4, code A).